In Vitro Diagnostic Reagents Market

In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.

In Vitro Diagnostic Reagents Market contains market size and forecasts of In Vitro Diagnostic (IVD) Reagents in global, including the following market information:

Global In Vitro Diagnostic (IVD) Reagents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global In Vitro Diagnostic (IVD) Reagents Market Sales, 2017-2022, 2023-2028, (Million Units)

Global top five In Vitro Diagnostic (IVD) Reagents companies in 2021 (%)

The global In Vitro Diagnostic (IVD) Reagents market was valued at 39480 million in 2021 and is projected to reach US$ 55820 million by 2028, at a CAGR of 5.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In Vitro Diagnostic (IVD) Reagents include Roche, Danaher, Abbott Laboratories, Thermal Fisher, Sysmex Corporation, Biomerieux, Siemens, Ortho Clinical Diagnostics and BD, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the In Vitro Diagnostic (IVD) Reagents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In Vitro Diagnostic (IVD) Reagents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Million Units)

Global In Vitro Diagnostic (IVD) Reagents Market Segment Percentages, by Type, 2021 (%)

Immune Diagnosis

Clinical and Biochemical

Molecular Diagnosis

POCT

Other

Global In Vitro Diagnostic (IVD) Reagents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Million Units)

Global In Vitro Diagnostic (IVD) Reagents Market Segment Percentages, by Application, 2021 (%)

Hospital

Laboratory

Other

Global In Vitro Diagnostic (IVD) Reagents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Million Units)

Global In Vitro Diagnostic (IVD) Reagents Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In Vitro Diagnostic (IVD) Reagents revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies In Vitro Diagnostic (IVD) Reagents revenues share in global market, 2021 (%)

Key companies In Vitro Diagnostic (IVD) Reagents sales in global market, 2017-2022 (Estimated), (Million Units)

Key companies In Vitro Diagnostic (IVD) Reagents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Danaher

Abbott Laboratories

Thermal Fisher

Sysmex Corporation

Biomerieux

Siemens

Ortho Clinical Diagnostics

BD

Bio-Rad

Myriad Genetics

Hologic

QIAGEN

Mindray Medical

Wondfo

KHB

Da An Gene

Leadman

Biosino